梅州哪家人流做的好(梅州十七岁女孩怀孕怎么办) (今日更新中)

A senior State Department official who appeared to have extravagantly padded her resume and to have touted a fake TIME magazine cover to bolster her standing has resigned, 184

A pinch in the leg, a squeal and a trickle of tears. One baby after another in Malawi is getting the first and only vaccine against malaria, one of history’s deadliest and most stubborn of diseases.The southern African nation is rolling out the shots in an unusual pilot program along with Kenya and Ghana. Unlike established vaccines that offer near-complete protection, this new one is only about 40% effective. But experts say it’s worth a try as progress against malaria stalls: Resistance to treatment is growing and the global drop in cases has leveled off. With the vaccine, the hope is to help small children through the most dangerous period of their lives. Spread by mosquito bites, malaria kills more than 400,000 people every year, two-thirds of them under 5 and most in Africa.Seven-month-old Charity Nangware received a shot on a rainy December day at a health clinic in the town of Migowi. She watched curiously as the needle slid into her thigh, then twisted up her face with a howl.“I’m very excited about this,” said her mother, Esther Gonjani, who herself gets malaria’s aches, chills and fever at least once a year and loses a week of field work when one of her children is ill. “They explained it wasn’t perfect, but I feel secure it will relieve the pain.”There is little escaping malaria -- “malungo” in the local Chichewa language -- especially during the five-month rainy season. Stagnant puddles, where mosquitoes breed, surround the homes of brick and thatch and line the dirt roads through tea plantations or fields of maize and sugar cane. In the village of Tomali, the nearest health clinic is a two-hour bike ride away. The longer it takes to get care, the more dangerous malaria can be. Teams from the clinic offer basic medical care during visits once or twice a month, bringing the malaria shot and other vaccines in portable coolers. Treating malaria takes up a good portion of their time during the rainy season, according to Daisy Chikonde, a local health worker.“If this vaccine works, it will reduce the burden,” she said.Resident Doriga Ephrem proudly said her 5-month-old daughter, Grace, didn’t cry when she got the malaria shot.When she heard about the vaccine, Ephrem said her first thought was “protection is here.” Health workers explained, however, that the vaccine is not meant to replace antimalarial drugs or the insecticide-treated bed net she unfolds every night as the sun sets and mosquitoes rise from the shadows. “We even take our evening meals inside the net to avoid mosquitoes,” she said.It took three decades of research to develop the new vaccine, which works against the most common and deadly of the five parasite species that cause malaria. The parasite’s complex life cycle is a huge challenge. It changes forms in different stages of infection and is far harder to target than germs.“We don’t have any vaccines against parasites in routine use. This is uncharted territory,” said Ashley Birkett, who directs PATH’s Malaria Vaccine Initiative, a nonprofit that helped drugmaker GlaxoSmithKline develop the shot, brand-named Mosquirix. The bite of an infected mosquito sends immature parasites called sporozoites into the bloodstream. If they reach the liver, they’ll mature and multiply before spewing back into the blood to cause malaria’s debilitating symptoms. At that point, treatment requires medicines that kill the parasites.Mosquirix uses a piece of the parasite — a protein found only on sporozoites’ surface — in hopes of blocking the liver stage of infection. When a vaccinated child is bitten, the immune system should recognize the parasite and start making antibodies against it.Scientists also are searching for next-generation alternatives. In the pipeline is an experimental vaccine made of whole malaria parasites dissected from mosquitoes’ salivary glands but weakened so they won’t make people sick. Sanaria Inc. has been testing its vaccine in adults, and is planning a large, late-stage study in Equatorial Guinea’s Bioko Island.And the U.S. National Institutes of Health soon will start initial tests of whether injecting people periodically with lab-made antibodies, rather than depending on the immune system to make them, could offer temporary protection during malaria season. Think of them as “potentially short-term vaccines,” NIH’s Dr. Robert Seder told a recent meeting of the American Society of Tropical Medicine and Hygiene.For now, only babies in parts of Malawi, Kenya and Ghana are eligible for the Mosquirix vaccine. After the vaccine was approved in 2015, the World Health Organization said it first wanted a pilot roll-out to see how well it worked in a few countries — in real-world conditions — before recommending that the vaccine be given more widely across Africa. “Everyone is looking forward to getting it,” said Temwa Mzengeza, who oversees Malawi’s vaccine programs. Those eager for the shots include her husband, whom she had to stop from trying to get them, she said.Mzengeza used to come down with malaria several times a year until she started following her own advice to sleep under a net every night. Unlike many other kinds of infections, people can get malaria repeatedly, building up only a partial immunity.In the pilot program that began last year, 360,000 children in the three countries are meant to be vaccinated annually. The first dose is given at about age 5 months and the final, fourth booster near the child’s second birthday.Experts say it is too early to know how well the vaccine is working. They’re watching for malaria deaths, severe infections and cases of meningitis, something reported during studies but not definitively linked to the vaccine.“To do something completely new for malaria is exciting,” said researcher Don Mathanga, who is leading the evaluation in Malawi. The rainy season has brought new challenges, making some rural roads impassable and complicating efforts to track down children due for a shot. So far in Malawi, the first dose reached about half of the children targeted, about 35,000. That dropped to 26,000 for the second dose and 20,000 for the third. That’s not surprising for a new vaccine, Mzengeza said. “It will pick up with time.”At the health clinic in Migowi in Malawi’s southern highlands, workers see signs of hope. Henry Kadzuwa explains the vaccine to mothers waiting at the clinic. He said there was a drop in malaria cases to 40 in the first five months of the program, compared to 78 in the same period in 2018.Even though he wishes his 3-year-old daughter, Angel, could receive the vaccine, “it’s protecting my community. It also makes my work easier,” Kadzuwa said. The Migowi area has one of the country’s highest rates of malaria, and a worn paper register in the clinic’s laboratory lists scores of cases.At the clinic, Agnes Ngubale said she had malaria several years ago and wants to protect her 6-month-old daughter, Lydia, from the disease.“I want her to be healthy and free,” she said. “I want her to be a doctor.”And she has memorized the time for Lydia’s second dose: “Next month, same date.”___Neergaard reported from Washington.___The Associated Press Health and Science Department receives 7200

After originally not having a briefing scheduled, the White House opted Tuesday afternoon to hold a briefing to deliver an update as cases of COVID-19 continue to increase nationwide. As of Tuesday afternoon, there are more than 51,000 coronavirus cases throughout the United States, according to John Hopkins University data. In the last two days, the tone coming from the White House has shifted from one of preparedness to one of trying to reopen segments of the economy. On Monday, President Donald Trump said that “we cannot let the cure be worse than the problem itself," suggesting that the economic impact of the nation's coronavirus response could be worse than the spread of the virus. Trump said that he believes that the United States can “do both” protect lives and reopen the economy. On Tuesday, Trump said on Fox News that he has a goal to have the economy “opened up and just raring to go by Easter.”At the White House's briefing on Tuesday, Trump said that data would inform his decision. But when asked why he made Easter a target date, he said that it's a "special day."Dr. Anthony Fauci, who has been advising the White House through this crisis, said that any goals should be flexible. But Trump’s approach is at odds of many state governors and health directors. In New York, which has seen nearly half the number of US cases of coronavirus, Gov. Andrew Cuomo gave a dire proclamation of what is to happen in the weeks to come. “FEMA says we're sending 400 ventilators. Really? What am I going to do 400 ventilators when I need 30,000?” Cuomo said. “You pick the 26,000 people who are going to die because you only sent 400 ventilators.”Meanwhile, the US Senate is nearing an agreement on a multi-trillion-dollar bill to offer assistance to companies and individuals affected by the economic impacts of the coronavirus. "I just finished a very productive meeting with secretary Mnuchin, the white house congressional liaison Eric Ueland and Mark Meadows, the president's acting chief of staff,” Senate Minority Leader Chuck Schumer. “Last night, I thought we were on the five yard line. Right now we're on the two.” 2150

Alabama Gov. Kay Ivey on Wednesday signed into law a controversial abortion bill that could punish doctors who perform abortions with life in prison."Today, I signed into law the Alabama Human Life Protection Act, a bill that was approved by overwhelming majorities in both chambers of the Legislature," said Ivey, a Republican, in a statement. "To the bill's many supporters, this legislation stands as a powerful testament to Alabamians' deeply held belief that every life is precious and that every life is a sacred gift from God."The 550

AKRON, Ohio — More than 200 Ellet High School students received their diplomas Friday night at Akron Civic Theatre in Ohio. Among them was an 87-year-old man getting an honorary diploma, 70 years after he left school for the military.Floyd Edward Hoskins, known to friends and family members as Ed, left Ellet High School in 1949 at age 17 to join the military.“Three years, three months, 19 days,” Hoskins said of his total time in the Army. During that time, he said, he was supposed to serve in Korea but was sent to Alaska for two years instead.When he came home, Hoskins said he initially had trouble finding a job but eventually landed one at Goodyear Tire and Rubber, where he worked for “44 years, four months, three weeks and one day.”Hoskins moved to Hawaii two years ago to live with one of his sons and his daughter-in-law. His daughter-in-law, Cynthia Allen Hoskins, began doing some research into veterans’ benefits.“We are retired military, my husband and I,” Cynthia Allen Hoskins said. “And we were doing some research as far as our kids and their benefits in order to continue their college education.”She ran across information about the benefits the State of Ohio provides to veterans, where she learned her father-in-law might be eligible to receive his high school diploma. She inquired with his former school and found out he was eligible.“His reaction was kind of, ‘Ah, I don’t know if I really want to do this. It’s just a piece of paper,’ ” Cynthia Allen Hoskins said. “But after we explained to him, ‘Dad, you know, you really pushed education on us, we push it onto the grandkids. So why not?’ You know, if this is something that you deserve, go for it.”She said her father-in-law eventually came around to the idea.On Friday, when asked if he ever thought this day would come, Ed Hoskins said, “No, never.”“It’s an honor, but it’s scary,” he said, tearing up. “I’m not used to being in the limelight.”Decades older than his fellow graduates, Ed Hoskins received his diploma first, to loud applause. 2039

来源：资阳报